Health Care
Health Care
Data delayed at least 15 minutes, as of Jan 12 2026 22:17 GMT.
More ▼
Industries
| Today's change | 1 year change | |
|---|---|---|
| Medical Equipment and Services | -0.75% | +0.05% |
| Pharmaceuticals and Biotechnology | +0.31% | +21.68% |
| Listing | Last | Change | Volume | |
|---|---|---|---|---|
| GeoVax Labs IncGOVX:NAQ | 3.57 USD | +3.40 +2,055.80% | 469.47k | |
| Akanda CorpAKAN:NAQ | 2.63 USD | +2.14 +437.39% | 3.59m | |
| Biodesix IncBDSX:NMQ | 8.08 USD | +2.62 +47.99% | 75.53m | |
| Jiangsu Recbio Technology Co Ltd2179:HKG | 5.72 HKD | +1.56 +37.50% | 291.50k | |
| IRIDEX CorpIRIX:NAQ | 1.48 USD | +0.33 +28.70% | 657.55k | |
| BIOAGE Labs IncBIOA:NSQ | 17.85 USD | +3.82 +27.23% | 1.90m | |
| Soho Global Health Tbk PTSOHO:JKT | 2,570.00 IDR | +510.00 +24.76% | 1.63m | |
| Forte Biosciences IncFBRX:NAQ | 29.66 USD | +5.78 +24.20% | 423.45k | |
| Foghorn Therapeutics IncFHTX:NMQ | 6.38 USD | +1.22 +23.64% | 387.20k | |
| Cellectar Biosciences IncCLRB:NAQ | 3.80 USD | +0.72 +23.38% | 1.16m |
Data delayed at least 15 minutes, as of Jan 12 2026 21:00 GMT.
Sector news
- Healthcare M&A: Titans on spree as regulatory crackdown falls flat
- Private healthcare is far from a cure all
- Biogen drug slows progress of motor neurone disease in landmark trial
- Anthony Fauci warns Covid politics could harm childhood vaccination efforts
- At least 17mn people in Europe have had long Covid, says WHO
- Philips: sleep devices could mean costly problems lie ahead
- Pandemic exposes sharp divide in European cancer treatment
- Spire rides wave of demand for private healthcare
- CVS buys home healthcare group Signify Health for $8bn
- US lab at the centre of legal fight over Zantac and cancer
More ▼
